Prescription sales, which made up nearly two
thirds of the company's total sales, rose 9.3 percent in the
fourth quarter ended Aug. 31.
Total revenue rose to $19.06 billion in the quarter from $17.94
billion a year earlier.
The net loss attributable to the company was $239 million, or 25
cents per share, in the quarter, and included an $866 million
non-cash loss due to the amendment and exercise of its Alliance
Boots call option.
Walgreen posted a profit of $657 million, or 69 cents per share,
a year earlier.
Excluding items, the company earned 74 cents per share in the
latest quarter.
The company's shares rose 3.2 percent to $61.50 in trading
before the bell on Tuesday.
(Reporting by Nandita Bose in Chicago and Sruthi Ramakrishnan in
Bangalore; Editing by Savio D'Souza)
[© 2014 Thomson Reuters. All rights
reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|
|